Alobresib
Alobresib (Vorolanib) is a BET bromodomain inhibitor developed as an investigational anticancer agent. It has demonstrated antitumor activity in preclinical studies, including in vitro assays and in vivo models, supporting its research in oncology and targeted therapy.
Product Specifications
CAS Number
1637771-14-2
Product Name Alternative
Epigenetic Reader Domain, EpigeneticReaderDomain, GS5829, GS-5829, GS 5829, Inhibitor, inhibit, BET, Alobresib, Vorolanib
Field of Research
Epigenetics & Chromatin
Purity
97.63% (May vary between batches)
Solubility
DMSO:27.5 mg/mL (62.86 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.57 mM)
Smiles
Cc1noc (C) c1-c1cc (c2[nH]c (nc2c1) C1CC1) C (O) (c1ccccn1) c1ccccn1
Molecular Formula
C26H23N5O2
Molecular Weight
437.49
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1084960-01 0.05 mg (E-Coli)
Recombinant Beta vulgaris Pollen allergen Beta v 1
Sign In for Pricing
View Details MBS1084960-02 0.2 mg (E-Coli)
Recombinant Beta vulgaris Pollen allergen Beta v 1
Sign In for Pricing
View Details